Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2016
DelveInsight’s, “Microbiome- Competitive Landscape, Technology and Pipeline Analysis, 2016”, report provides comprehensive insights about pipeline drugs across microbiome. Key objective of the report is to establish the understanding for all the pipeline drugs that fall under Microbiome.
This report provides information on the therapeutic development based on the Microbiome dealing with all the pipeline drugs, comparative analysis of Microbiome at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the company’s information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Microbiome Pipeline scenario Collaborations & partnering deals Current Prominent Research Areas and Key Players Pipeline product profiles Microbiome Technologies and Targeted Antigens Licensing opportunities Market Drivers and Barriers
Overview of the global Microbiome pipeline scenario, products and associated companies information Coverage of global Microbiome under development Competitive landscape of products for key players Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities Highlights of licensing & collaboration opportunities and funding details Highlights of latest Microbiome technologies and innovative companies